Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Ratings
AstraZeneca’s Promising Future: Buy Rating Backed by Robust Pipeline and Strong Sales Potential
1d ago
AZN
Premium
Ratings
AstraZeneca’s Promising Pipeline and Market Potential Drive Buy Rating Amid Positive Competitor Data
2d ago
AZN
Premium
The Fly
Ionis and AstraZeneca’s WAINZUA gets EU approval for ATTRv-PN treatment
2d ago
AZN
IONS
Premium
The Fly
AstraZeneca announces MATTERHORN trial results
5d ago
AZN
Premium
The Fly
AstraZeneca’s MATTERHORN Phase III trial showed improvement in endpoint of EFS
5d ago
AZN
Premium
The Fly
AstraZeneca says Imfinzi-based perioperative regimen recommended for EU approval
9d ago
AZN
Premium
Ratings
AstraZeneca’s Growth Potential Highlighted by Positive Risk-Reward Scenario and Strategic Drug Portfolio
9d ago
AZN
Premium
The Fly
AstraZeneca added to European Conviction List at Goldman Sachs
9d ago
AZN
Premium
The Fly
Amgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire
10d ago
AZN
AMGN
Premium
The Fly
AIM announces principal investigator for Ampligen, FluMist clinical study
12d ago
AIM
AZN
Premium
The Fly
AstraZeneca Enhertu recommended for approval in EU by CHMP
12d ago
AZN
Premium
The Fly
AstraZeneca, Daiichi Sankyo’s Enhertu recommended for approval in EU
12d ago
AZN
Premium
The Fly
AstraZeneca data ‘positive’ for Olema’s palazestrant, says H.C. Wainwright
14d ago
AZN
OLMA
Premium
The Fly
AstraZeneca reports SERENA-6 trial shows improvement in the primary endpoint
14d ago
AZN
Premium
The Fly
AstraZeneca announces results from interim analysis of SERENA-6 Phase III trial
14d ago
AZN
Premium
Ratings
AstraZeneca’s Promising Pipeline and Positive Trial Results Justify Buy Rating
14d ago
AZN
Premium
The Fly
AIM ImmunoTech doses first subject in Phase 2 study of Ampligen, Imfinzi
15d ago
AIM
AZN
Premium
Ratings
Strategic Acquisition and Market Expansion Drive AstraZeneca’s Buy Rating
17d ago
AZN
Premium
The Fly
FDA posts observations from AstraZeneca site inspection
20d ago
AZN
Premium
The Fly
FibroGen China sale ‘shrewd strategic transaction,’ says H.C. Wainwright
20d ago
AZN
FGEN
Premium
The Fly
FibroGen selling FibroGen China to AstraZeneca for $160M
20d ago
AZN
FGEN
Premium
The Fly
Soros buys Arthur J. Gallagher, boosts Accenture in Q4
26d ago
J
SW
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
